Atlas Trials

Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia

Clinical trial NCT06708572 · RECRUITING

Trial details

NCT number
NCT06708572
Sponsor
National Liver Institute, Egypt
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Granulocyte Colony-stimulating FactorBiliary Atresia
Start date
2024-12-01
Primary completion
2026-10-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.